ENNVW $0.40 0%
CLW $31.38 -1.784%
SSPGX $0.52 0%
HMY $5.10 2.4096%
VCT.L $1 520.00 0.5291%
0174.HK $0.51 8.5106%
C40.PA $118.04 0.34%
LITB $1.30 2.3622%
AVO.L $6.50 0%
KCNY $35.30 10.3988%
ADERU $10.71 0%
0QYL.L $49.97 1.5794%
0H14.L $4.96 -0.0805%
SLI $3.52 -1.1208%
QRF.BR $11.40 0%
GRF.MC $11.11 0.8167%
SUD5.L $18.30 0%
PTNT4.SA $6.54 3.481%
5JK.SI $0.74 1.3699%
AOM $39.77 -0.5253%
FDFIX $17.64 -0.1133%
0QKQ.L $6.75 -1.9884%
0HAV.L $126.94 0.0197%
OOUT.L $10.20 0%
ALVIA.PA $14.00 0%
MDC.L $493.40 -0.4037%
RSGL.L $24 824.00 0.8081%
CPP.L $208.00 1.9608%
IUSB $46.05 -0.3894%
POLA $1.43 -3.3784%
CLIN.L $925.00 0%
BUYB.L $42.64 -0.1756%
MLPRX.PA $0.40 0%
HUMA $3.92 -7.6561%
G92.SI $0.90 -1.105%
RTWG.L $98.90 0%
PIRS $0.86 -9.3251%
CIT $53.50 0%
2877.HK $9.28 -0.2151%
0P0000SHY8.L $13 394.30 0.828%
CARR.L $121.50 0%
FAN $17.79 0.9098%
CHIN.L $11.75 -0.2971%
1912.HK $0.07 -1.5152%
IOO $72.45 -0.6445%
ENSV $0.35 5.5741%
0J6Z.L $529.10 0.0189%
EFC-PA $19.55 0.2127%
MMLP $2.27 -5.6083%
CHN $11.44 -2.5554%
SLVO $78.03 -0.8765%
NVD2.L $126.84 -2.1183%
JJEB $51.74 0%
BAC-PP $17.69 0.1653%
BKKT $1.30 0.7752%
LCII $105.56 -3.3068%
MDYV $62.97 -0.7409%
0984.HK $0.84 -1.1765%
PAVE.L $25.37 0.1381%
PTIC $10.73 0%
NBA-WT $1.06 0%
KMB $143.63 -0.0383%
8509.HK $0.32 -3.0769%
LMS.L $23.10 4.5249%
MDWT $25.79 0.1553%
FLR $25.83 -2.3809%
HNI $27.41 -0.291%
SHO-PI $18.94 -0.2633%
ANXU.L $150.38 -0.5555%
GBCI $27.05 -0.8614%
AUTO.L $631.00 -0.2844%
0ZFN.L $15.66 -1.5252%
0NJB.L $31.90 1.9169%
NOVVR $0.30 0%
MEIP $6.95 -0.1437%
ALOSM.PA $10.10 1%
SUMO $12.04 -0.083%
GEN.BR $19.08 -1.2167%
ARIX.L $106.50 1.4286%
NTSE $27.35 -1.5323%
2836.HK $33.64 -0.1188%
GQRE $52.56 -0.5111%
NERD.CN $0.06 -15.3846%
SRC $38.09 -0.962%
TMP $49.94 -1.2458%
USBF $86.22 1.26857%
BSIF.L $136.60 0%
1343.HK $0.12 2.5862%
3306.HK $8.00 -3.2648%
QELL $9.41 0%
3319.HK $5.68 -1.8998%
BSE.L $9.45 -5.5%
CFO $61.06 -0.3102%
FWONK $71.83 0.6163%
1066.HK $12.62 -2.1705%
DUKE.L $30.50 1.6667%
FHLT $10.15 1.8054%
AUG.L $371.00 0%
0602.HK $0.05 -9.0909%
SFYF $23.33 -1.9187%
Eng
Логотип
Eng
Лого

Nuformix plc NFX.L

$0.27

На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    1935203.00000000

  • week52high

    0.95

  • week52low

    0.21

  • Revenue

    50000

  • P/E TTM

    -156

  • Beta

    0.45229000

  • EPS

    0.00000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    30 июн 2023 г. в 10:59

Описание компании

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек